Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | no genetic evidence; overall 0.08 from other evidence | 0.00 |
| cell type Human Protein Atlas | expressed broadly, no clear home in brain cells | 0.40 |
| chemistry Open Targets | a small-molecule pocket | 0.60 |
| trials ClinicalTrials.gov | no Parkinson's trials on record: an open field | 1.00 |
| literature PubMed | 1 Parkinson's papers of 424 | 0.91 |
| pathways Reactome | 5 pathways; mostly protein handling | 0.90 |
No case: the score is under the bar. Receipt 3542
Sealed predictions
- CTBP1 in dopamine neurons, braak-0.86 (p 0.003) → -0.55 (p 0.123)receipt 3547
Swarm cases
receipt 3547: CTBP1 in dopamine neurons, braak
- power
- full sample -0.74 (p 4.4e-4, n 18), 95% CI -0.90 to -0.42. the interval excludes zero: something may be there, smaller than a half can see.
- confounder
- adjusted for sex: -0.78 (p 1.4e-4, n 18). holds up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.79 (p 1.1e-4, n 18). not the mix.
- skeptic
- leave-one-out range -0.81 to -0.71, sign flips 0; without severely affected donors -0.74 (p 4.4e-4, n 18). robust.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for CTBP1 in dopamine neurons.
case closed: nothing better to follow up.
Receipts
loading the receipts